Geron | GERN - Selling And Administration Expenses


Geron reported $39M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Amgen USD 1.7B 9M Sep/2025
Bio Techne USD 116.21M 80.43M Sep/2025
Cassava Sciences USD 7.9M 1.08M Sep/2025
Cytokinetics USD 158.75M 93.03M Sep/2025
Exelixis USD 103.13M 9.8M Sep/2025
Genmab DKK 144M 18M Jun/2025
Geron USD 39M 437K Sep/2025
Gilead Sciences USD 1.35B 6M Sep/2025
Incyte USD 329.08M 1.94M Sep/2025
MacroGenics USD 9.9M 600K Sep/2025
Novartis USD 3.31B 134M Sep/2025